Shandong Bainuo Pharmaceutical DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

Sanofi sells controlling stake of consumer health unit for €10B

01 May 2025

// PRESS RELEASE

Novartis to buy Regulus in up to $1.7 Billion deal

01 May 2025

// REUTERS

US FDA approves J&J's immune disorder drug

01 May 2025

// PRESS RELEASE

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

Iran Expo

Not Confirmed

Book a meeting

envelop Contact Supplier

Latest Content

radio-compass-blog/how-trump-s-tariffs-on-imported-drugs-can-hurt-supply-chains-consumers-and-industry

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

About

Shandong Bainuo Pharmaceutical Co., Ltd. was established in August 2000 and is headquartered in Jinan City, Shandong Province. It is committed to building a leading pharmaceutical R&D technology platform company in China. It has passed the ISO9001 international quality management system and intellectual property management system certification, and established the "R&D Industry " Academician Workstation" , the vice-chairman unit of the Pharmaceutical Research and Development Branch of the All-China Federation of Industry and Commerce, and obtained the "Drug Production License" of the first research institution in Shandong Province.